AN2 Therapeutics, Inc. - Common Stock, par value $0.00001 per share (ANTX)

CUSIP: 037326105

Q3 2024 13F Holders as of 30 Sep 2024

Type / Class
Equity / Common Stock, par value $0.00001 per share
Shares outstanding
37,347,828
Total 13F shares
13,513,224
Share change
-5,904,158
Total reported value
$14,458,906
Price per share
$1.07
Number of holders
31
Value change
-$16,315,888
Number of buys
15
Number of sells
29

Quarterly Holders Quick Answers

What is CUSIP 037326105?
CUSIP 037326105 identifies ANTX - AN2 Therapeutics, Inc. - Common Stock, par value $0.00001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of AN2 Therapeutics, Inc. - Common Stock, par value $0.00001 per share (ANTX) as of Q3 2024

As of 30 Sep 2024, AN2 Therapeutics, Inc. - Common Stock, par value $0.00001 per share (ANTX) was held by 31 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 13,513,224 shares. The largest 10 holders included BML Capital Management, LLC, RA CAPITAL MANAGEMENT, L.P., TCG Crossover Management, LLC, VANGUARD GROUP INC, Acuitas Investments, LLC, RENAISSANCE TECHNOLOGIES LLC, MILLENNIUM MANAGEMENT LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., BlackRock, Inc., and GEODE CAPITAL MANAGEMENT, LLC. This page lists 31 institutional shareholders reporting positions in this security for the Q3 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.